A
simple, direct urinary assay of pyridinium crosslinks and deoxypyridinoline,
useful in identifying current rate of bone loss, lytic bone disease,
and efficacy of bone support therapies.
The Bone Resorption Assessment from Great Smokies Diagnostic Laboratory
can improve the quality of life for women. This test Identifies elevated
levels of bone loss before excessive damage has occurred.
Enables regular testing of women for resorption rates, allowing treatment
intervention at its most effective-before bone loss has occurred.
Monitors
the effectiveness of calcium supplementation to slow bone loss and
rebuild bone.
To
order this test click here |
|
Using the two most specific markers of bone resorption, the Bone
Resorption Assessment measures bone loss accurately and inexpensively.
By discriminating between patients with high and low bone turnover—two
subgroups which benefit from different therapeutic approaches—health
care professionals can prescribe appropriate treatments and monitor
patient compliance and treatment effectiveness.
The Bone Resorption Assessment is also invaluable in studying osteoporosis
and the bone diseases associated with arthritis, metabolic bone
disease, and cancer. The noninvasive urine analysis assays pyridinium
crosslinks and deoxypyridinoline, two collagen crosslinks found
to be more specific for bone resorption than other collagen metabolites,
such as telopeptides.
All lab tests can be done through the mail in the privacy of your
own home, except blood tests, we send you to a lab to have your
blood drawn for these. After you pay for the test we mail you the
kit, the results take two weeks, the test results will be mailed
to us and we will call you to go over the results, its that easy!
All tests include the consultation for the report of findings.
Click on test of interest on the right for more information
Call our office for details.
800-956-7083 OR 818-707-3126
|